Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers
Recruiting
Observational Study
Multiple Myeloma (MM)
Hematologic Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 190 (estimated)
- Sponsor
- Azienda USL Reggio Emilia - IRCCS · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Individuals with multiple myeloma (MM) are vulnerable because of the effects of systemic organ damage and the side effects of treatment. A decline in patients' health-related quality of life (HRQoL) and a compromised participation in everyday life was reported. The diagnosis of MM negatively affects the principal informal caregiver. This is a concurrent exploratory mixed methods study that involve…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria for individuals with MM will be:
1. diagnosis of MM
2. adulthood (≥ 18 years)
3. in treatment (LOT I, II, or ≥ III) at the Hematology Unit
4. speak Italian fluently
Exclusion Criteria:
Comorbidities that limit collaboration (e.g., dementia, severe psychiatric disorders).
\_\_\…
Contacts